Showing results (71-80 of 116) with videos related to
Sort By:
Pageof 12
Acta Oncologica (Stockholm, Sweden)|August 2, 2017
Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcomeAnnika Englund, Ingrid Glimelius, Klaus Rostgaard, et al.Scandinavian Journal of Urology|April 13, 2026
Complications and clinical outcomes of retroperitoneal lymph node dissection for testicular cancer in a centralized population-based cohort in Sweden: insights from SWENOTECAAnna Thor, Anna Grenabo Bergdahl, Armin Abniki, et al.Hemasphere|March 19, 2025
Ibrutinib, lenalidomide, and rituximab in relapsed mantle cell lymphoma: Long-term follow-up of the Nordic Lymphoma Group MCL6 Philemon trialElin Forsgren, Rasmus R K Jørgensen, Hans Bentzen, et al.Cancer Causes & Control : CCC|December 21, 2023
Associations between pregnancy-related factors and birth characteristics with risk of rare uterine cancer subtypes: a Nordic population-based case-control studyJazmine Abril, Britton Trabert, Rebecca Troisi, et al.British Journal of Cancer|April 28, 2020
Pregnancy-related risk factors for sex cord-stromal tumours and germ cell tumours in parous women: a registry-based studyCamilla Sköld, Tone Bjørge, Anders Ekbom, et al.Ejhaem|July 18, 2022
Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survivalTor Persson Skare, Elin Sjöberg, Mattias Berglund, et al.British Journal of Haematology|August 5, 2020
p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphomaJoana M Rodrigues, May Hassan, Catja Freiburghaus, et al.British Journal of Cancer|December 21, 2025
High-dose chemotherapy in male germ cell cancer patients-a study by the SWENOTECA groupAnna K Jansson, Gabriella Cohn-Cedermark, Helene F S Negaard, et al.Blood Advances|June 30, 2023
Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphomaAnna Nikkarinen, Lavanya Lokhande, Rose-Marie Amini, et al.Journal of Cancer Policy|April 6, 2026
Comprehensive Cancer Care in the Nordic Countries; strengths, opportunities and improvement profilesMef Nilbert, Lovisa Lesand, Maria Hernandez Mesa, et al.Pageof 12